Moneta Group Investment Advisors LLC Crispr Therapeutics Ag Transaction History

Moneta Group Investment Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$53.19 - $79.24 $183,186 - $272,902	-3,444 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$70.09 - $111.29 $10,934 - $17,361	-156 Reduced 4.33%	3,444 $261,000
Q3 2021 Nov 12, 2021	BUY	$110.2 - $156.64 $5,289 - $7,518	48 Added 1.35%	3,600 $403,000
Q2 2021 Aug 13, 2021	BUY	$100.84 - $161.89 $705 - $1,133	7 Added 0.2%	3,552 $575,000
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $392,502 - $744,591	3,545 New	3,545 $432,000

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.69B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Moneta Group Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Moneta Group Investment Advisors LLC with notifications on news.